Robin Wright - Net Worth and Insider Trading

Robin Wright Net Worth

The estimated net worth of Robin Wright is at least $63,698 dollars as of 2024-06-23. Robin Wright is the Director of Barinthus Biotherapeutics PLC and owns about 48,256 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $63,698. Details can be seen in Robin Wright's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robin Wright has not made any transactions after 2023-05-25 and currently still holds the listed stock(s).

Transaction Summary of Robin Wright

To

Robin Wright Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robin Wright owns 1 companies in total, including Barinthus Biotherapeutics PLC (BRNS) .

Click here to see the complete history of Robin Wright’s form 4 insider trades.

Insider Ownership Summary of Robin Wright

Ticker Comapny Transaction Date Type of Owner
BRNS Barinthus Biotherapeutics PLC 2023-05-25 director

Robin Wright Latest Holdings Summary

Robin Wright currently owns a total of 1 stock. Robin Wright owns 48,256 shares of Barinthus Biotherapeutics PLC (BRNS) as of May 25, 2023, with a value of $63,698.

Latest Holdings of Robin Wright

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BRNS Barinthus Biotherapeutics PLC 2023-05-25 48,256 1.32 63,698

Holding Weightings of Robin Wright


Robin Wright Form 4 Trading Tracker

According to the SEC Form 4 filings, Robin Wright has made a total of 3 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 13,750 shares on May 25, 2023, which cost Robin Wright around $36,575.

Insider Trading History of Robin Wright

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robin Wright Trading Performance

GuruFocus tracks the stock performance after each of Robin Wright's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robin Wright is -17.01%. GuruFocus also compares Robin Wright's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robin Wright within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robin Wright's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robin Wright

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.56 LIMIT LIMIT LIMIT LIMIT LIMIT

Robin Wright Ownership Network

Ownership Network List of Robin Wright

No Data

Ownership Network Relation of Robin Wright

Insider Network Chart

Robin Wright Owned Company Details

What does Barinthus Biotherapeutics PLC do?

Who are the key executives at Barinthus Biotherapeutics PLC?

Robin Wright is the director of Barinthus Biotherapeutics PLC. Other key executives at Barinthus Biotherapeutics PLC include director & Chief Executive Officer William Enright , Chief Scientific Officer Nadege Pelletier , and Chief Financial Officer Gemma Brown .

Barinthus Biotherapeutics PLC (BRNS) Insider Trades Summary

Over the past 18 months, Robin Wright made 1 insider transaction in Barinthus Biotherapeutics PLC (BRNS) with a net purchase of 13,750. Other recent insider transactions involving Barinthus Biotherapeutics PLC (BRNS) include a net sale of 15,000 shares made by William Enright , a net purchase of 10,000 shares made by Joseph Scheeren ,

In summary, during the past 3 months, insiders sold 0 shares of Barinthus Biotherapeutics PLC (BRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,000 shares of Barinthus Biotherapeutics PLC (BRNS) were sold and 23,750 shares were bought by its insiders, resulting in a net purchase of 8,750 shares.

Barinthus Biotherapeutics PLC (BRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Barinthus Biotherapeutics PLC Insider Transactions

No Available Data

Robin Wright Mailing Address

Above is the net worth, insider trading, and ownership report for Robin Wright. You might contact Robin Wright via mailing address: The Schrodinger Building, Heatley Road, The Oxford Science Park, Oxford X0 Ox4 4ge.

Discussions on Robin Wright

No discussions yet.